St. Peters, MO, United States of America

Ronald Keith Webber

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Ronald Keith Webber

Introduction

Ronald Keith Webber is a notable inventor based in St. Peters, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate glucocorticoid receptor activity. With a total of 4 patents to his name, Webber's work has the potential to impact various medical conditions.

Latest Patents

Webber's latest patents include innovative tricyclic compounds and their compositions. These compounds are designed to act as modulators of the glucocorticoid receptor, which plays a crucial role in the treatment of conditions mediated by glucocorticoid receptor activity. The compounds and their salts are aimed at providing therapeutic benefits in managing these conditions.

Career Highlights

Webber is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements in drug formulations and therapeutic methods.

Collaborations

Throughout his career, Webber has collaborated with talented individuals such as Xiao Hu and Kevin D Jerome. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Ronald Keith Webber's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…